Log In
Print this Print this

OXi4503, combretastatin A1 di-phosphate (CA1P)

Also known as: OXi-4503

  Manage Alerts
Collapse Summary General Information
Company Mateon Therapeutics Inc.
DescriptionVascular disrupting agent
Molecular Target Tubulin
Mechanism of ActionMicrotubule depolymerization
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today